Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma.

Autor: Ng KYY; Division of Population Health and Integrated Care, Singapore General Hospital, Singapore, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Teo AEK; Division of Internal Medicine, Singapore General Hospital, Singapore, Singapore., Tan SH; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore.; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore., Tan JJE; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tay DSH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lee AWX; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ang AJS; Division of Internal Medicine, Singapore General Hospital, Singapore, Singapore., Wong LWJ; Division of Pediatrics, KK Women and Children's Hospital, Singapore, Singapore., Choo SP; Curie Oncology, Singapore, Singapore., Toh HC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Lee SY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Lee JJX; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Tai DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore.

Publikováno v: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.

Autor: Ng KYY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Tan SH; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Tan JJE; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tay DSH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lee AWX; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ang AJS; Division of Internal Medicine, Singapore General Hospital, Singapore, Singapore., Wong LWJ; Division of Pediatrics, KK Women and Children's Hospital, Singapore, Singapore., Choo SP; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Curie Oncology, Singapore, Singapore., Tai DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore., Lee JJX; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Program, Duke-NUS Medical School, Singapore, Singapore.

Publikováno v: Liver cancer [Liver Cancer] 2021 Oct 26; Vol. 11 (1), pp. 9-21. Date of Electronic Publication: 2021 Oct 26 (Print Publication: 2022).

Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors.

Autor: Mustafayev, Khalis¹, Mallet, Vincent², Torres, Harrys A.^1,3 htorres@mdanderson.org

Publikováno v: Journal of Immunotherapy & Precision Oncology. May2024, Vol. 7 Issue 2, p111-121. 11p.

Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.

Autor: Xia, Zhengzheng^1,2 (AUTHOR), Zhang, Jianyu² (AUTHOR), Chen, Wenjun² (AUTHOR), Zhou, Haiyan¹ (AUTHOR), Du, Di³ (AUTHOR), Zhu, Kongcai⁴ (AUTHOR), Chen, Hui⁵ (AUTHOR), Meng, Jun² (AUTHOR) meng@cicams-sz.org.cn, Yang, Jun¹ (AUTHOR) yangjun_99@126.com

Publikováno v: Infectious Diseases of Poverty. 9/22/2023, Vol. 12 Issue 1, p1-18. 18p.

Hepatitis B Virus Reactivation in Cancer Patients Undergoing Immune Checkpoint Inhibitors Therapy: A Systematic Review.

Autor: Jian Zhao¹, Yuehua Zhang², Siyuan Qin³, Bingwen Zou⁴, Yongsheng Wang¹ zoubingwen81@163.com

Publikováno v: Journal of Cancer. 2022, Vol. 13 Issue 14, p3539-3553. 15p.